The assay is the first to receive FDA 510(k) clearance and CLIA waiver for use with Diasorin's Liaison Nes platform.
SINGAPORE, Oct. 24, 2025 /PRNewswire/ -- Pfizer Singapore and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Health Sciences Authority has approved the companies' LP.8.1-adapted ...
The updated COVID-19 vaccine is expected to be available in Singapore at selected polyclinics and private general practitioner (GP) clinics in October 2025 for individuals 6 months of age and older.
São Carlos Institute of Physics, University of São Paulo, Av. João Dagnone, 1100─Jardim Santa Angelina, São Carlos 13563-120, Brazil ...
Introduction: The evolution of novel SARS-CoV-2 variants significantly affects vaccine effectiveness. While these effects can only be studied retrospectively, neutralizing antibody titers are most ...
A study revealed that Jun13296, a novel PLpro inhibitor, demonstrates potent antiviral and anti-inflammatory effects in vivo, offering hope for future COVID-19 therapies beyond Paxlovid. Study: Design ...
University of Arizona has identified non-structural protein 3 (nsp3; PL-pro) (SARS-CoV-2; COVID-19 virus) inhibitors reported to be useful for the treatment of SARS-CoV-2 infection (COVID-19).
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a significant public health issue worldwide in recent years. The most recently circulating variant of SARS-CoV-2, ...
A quite recent Japanese Sub-lineage of KP.3.3.10 with S:A435S (G22865T) and other mutations, 26 seqs
Geographic Distribution: 8 ,All Japan, but seems to be located in multiple region(prefecture) https://nextstrain.org/fetch/genome.ucsc.edu/trash/hgPhyloPlace ...
dDepartment of Hematology Leiden University Medical Centre, Leiden, Netherlands eDepartment of Cell and Chemical Biology, ONCODE Institute Leiden University Medical Centre, Leiden, Netherlands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results